![]() | This article includes alist of references,related reading, orexternal links,but its sources remain unclear because it lacksinline citations. Please helpimprove this article byintroducing more precise citations.(November 2011) (Learn how and when to remove this message) |
Jane Henney | |
---|---|
![]() | |
17th Commissioner of Food and Drugs | |
In office January 17, 1999 – January 19, 2001 | |
President | Bill Clinton |
Preceded by | David A. Kessler |
Succeeded by | Mark McClellan |
Personal details | |
Born | 1947 (age 77–78) Woodburn,Indiana,U.S. |
Education | Manchester University (B.A.) Indiana University School of Medicine (M.D.) University of Texas MD Anderson Cancer Center |
Jane Ellen Henney (born 1947) is an Americanphysician who was the first woman to serve as commissioner of the U.S.Food and Drug Administration. Appointed by PresidentBill Clinton, she served at the FDA from 1999 to 2001.[1]
Jane Henney was born inWoodburn, Indiana. She received her undergraduate training atManchester University, an MD degree fromIndiana University School of Medicine and did postgraduate work at theUniversity of Texas MD Anderson Cancer Center inHouston.[2] Trained as a medicaloncologist, she joined theNational Cancer Institute at theNational Institutes of Health in 1976, working in the Cancer Therapy and Evaluation Program.
Prior to her appointment as commissioner, Henney had worked at the FDA from 1992 to 1994 as deputy commissioner for operations under then-commissionerDavid Aaron Kessler, and then at theUniversity of New Mexico, where she was vice president of the health sciences center. After leaving the FDA she joined the board of directors of the pharmaceutical companyAstraZeneca.
A significant and far reaching decision by the FDA under her tenure, was the ban on supplements and natural products that containlovastatin, effectively handing exclusivity of cholesterol lowering compounds to pharmaceutical companies.AstraZeneca benefited directly from this decision this removed a cheap, natural product, from competing with their own statinrosuvastatin.
She was named senior vice president and provost for health affairs at theUniversity of Cincinnati in 2003. In 2012, she was appointed to the Board of Directors of Cubist Pharmaceuticals.[3]
![]() ![]() ![]() | This biographical article related to a physician in the United States is astub. You can help Wikipedia byexpanding it. |
![]() | This biography of a person who has held a non-elected position in the federal government of the United States is astub. You can help Wikipedia byexpanding it. |